#ICYMI: @RareRevolutionM published an issue focused on people impacted by #myelofibrosis. Hear from Jenny, who shares her inspiring story as she navigates living with a rare #bloodcancer.

About 30 minutes ago from GSK's Twitter

Seventeen new Fellows join the NHS Innovation Accelerator programme in 2023 zpr.io/PdYSf8A98fTp #NHSIA2023 #InnovationAccelerator #NHSInnovation #NHSFellows #HealthInnovation pic.twitter.com/Ui2ELzdFEX

About 2 hours ago from Pharma & Life Science News's Twitter

ABPI welcome the appointment of Sir Hugh Taylor to key role in Voluntary Scheme negotiations zpr.io/xPDiXWq6fTaK #ABPI #VoluntaryScheme #SirHughTaylor #PharmaceuticalIndustry #PatientCare pic.twitter.com/mdPZMRzlLu

About 2 hours ago from Pharma & Life Science News's Twitter

First European ChatGPT assistant to support physicians with medical, admin and personal tasks zpr.io/MmYPGZ36LWwk #ChatGPT #AIinMedicine #MedicalAssistance #PatientCare #FutureofHealthcare pic.twitter.com/D3n5YR77gd

About 2 hours ago from Pharma & Life Science News's Twitter

Reuters Events: Pharma USA 2023 unites all stakeholders across the value chain. See the website today to explore who you can expect to see at this year’s meeting: events.reutersevents.com/phar… pic.twitter.com/BTpDUbxLdV

About 2 hours ago from Pharma & Life Science News's Twitter

We have 4,749 Live Vacancies Today - zpr.io/phKncFmX2EEe Your Next Career Move Awaits! #pharma #biotech #medicaldevices #clinicalresearch #lifesciences pic.twitter.com/e5RlWEvs4L

About 5 hours ago from Pharma & Life Science News's Twitter

Evotec receives US$ 6.6 m grant for drug discovery in tuberculosis zpr.io/ZYWCVgyhtG7t #Tuberculosis #DrugDiscovery #EVOTEC #GrantFunding #Innovation pic.twitter.com/hd9lsvb8A2

About 7 hours ago from Pharma & Life Science News's Twitter

Evolva publishes agenda for 2023 Annual General Meeting zpr.io/eB3U8gLDaNJA #EvolvaAGM2023 #InnovativeBiotech #BiotechIndustry #AGM2023 #ScienceInnovation pic.twitter.com/lPw7OnnlOn

About 7 hours ago from Pharma & Life Science News's Twitter

On World TB Day let us pledge to end TB! Register to pharmaconnect.co.in to know more and keep yourself updated with the latest information on Health and the Pharma Industry. #WorldTBDay #pharma #networking #PharmaConnect @chetansuchak pic.twitter.com/PbeM6s8LGf

About 10 hours ago from Pharma Connect's Twitter

Low bone density, poor bone health linked to higher dementia risk medicalnewstoday.com/articles… #ScienceTwitter

About 10 hours ago from Medical News Today's Twitter

Heart failure: Exercise therapy is safe and helps improve recovery, study finds medicalnewstoday.com/articles… #ScienceTwitter

About 11 hours ago from Medical News Today's Twitter

Learn how a primary care department was able to reduce charting time for their physicians with these simple steps. spr.ly/60113CLAX

About 12 hours ago from AMA's Twitter

President of @TheNRMP breaks down the #Match2023 numbers, including match rates, changes by specialty, #SOAP2023 results, and what's in store for Class of 2024 #MatchDay. spr.ly/60113hiuH pic.twitter.com/UCH54R0ni6

About 13 hours ago from AMA's Twitter

Training is a key factor in keeping your #privatepractice staff up to date. Here are beneficial resources you can use. spr.ly/60193CLf9

About 14 hours ago from AMA's Twitter

Attending @theAMGA #AC23 next week? Stop by booth 419 to learn about our Health System Program resources! spr.ly/60133hiG7 pic.twitter.com/CntOjcNHAE

About 15 hours ago from AMA's Twitter

Ron Hirschberg, HMS brain injury expert and @homebaseprogram senior director of health and wellness, discusses the complex physical and mental wounds experienced by many veterans news.harvard.edu/gazette/stor…

Yesterday from Harvard Medical School's Twitter

We’re sharing positive results from a Phase 3 study of our medicine in adults with chronic obstructive pulmonary disease (COPD), a life-threatening disease in which no new treatment approaches have been approved in over a decade. bit.ly/3lzvelm CC: @Regeneron pic.twitter.com/hIAaLa5ONN

Yesterday from Sanofi US's Twitter

#MultipleMyeloma survivor Thomas shares his story from diagnosis at a young age, to continued treatment, his role in clinical trials, and life as an advocate: gsk.to/3LMhvCG #MultipleMyelomaAwarenessMonth pic.twitter.com/R1SH7drfrM

Yesterday from GSK US's Twitter

NICE backs PTC's Upstaza gene therapy for rare nervous system disorder $PTCT firstwordpharma.com/story/571…

Yesterday from FirstWord Pharma's Twitter

This March 27—30, the @ASAging #OnAging23 conference comes to Atlanta. Attendees can see PhRMA Deputy Vice Presidents Courtney Christian and Sharon Lamberton speak on this year's theme — health and wellness — and learn about health equity. For more: asaging.org/on-aging pic.twitter.com/0UZ9rfDmT6

Yesterday from PhRMA's Twitter

J&J loses a patent battle in India over a crucial tuberculosis drug.. statnews.com/pharmalot/2023… #pharma #patents #India #Tuberculosis $JNJ

Yesterday from pharmalot's Twitter

Continuing its focus on health equity, the Bristol Myers Squibb Foundation (a separate independent charitable organization) granted @PrincetonHealth $2.5MM to help support their new Geriatric Oncology Program to provide personalized care to people over 65. bit.ly/40eudyq

Yesterday from Bristol Myers Squibb's Twitter

Harvard Medical School neurobiologist Michael Greenberg has won the 2023 Brain Prize for pivotal insights into brain plasticity hvrd.me/LFuo50NqpZ0

Yesterday from Harvard Medical School's Twitter

DYK cancer mortality has decreased 33% since 1991? This incredible progress is driven in large part by innovative medicines. Unfortunately, some provisions in IRA that set the price of medicine could jeopardize future progress in cancer research. catalyst.phrma.org/ira-impact…

Yesterday from PhRMA's Twitter

“I just don’t understand why my health insurance gets more expensive year over year but covers less and less of the cost of my inhaler,” says Thomas, a Florida patient. Insurance should help you pay less for your medicines, not more. onphr.ma/3JgQG7E pic.twitter.com/6YPz0GsBEC

Yesterday from PhRMA's Twitter

Novo Nordisk Inks Deal with Dewpoint Therapeutics to Boost Diabetes Portfolio dlvr.it/SlN0mN pic.twitter.com/QMM66NfWc9

Yesterday from Pharmaceutical's Twitter

Skyrizi hits endpoints in late-stage ulcerative colitis study $ABBV firstwordpharma.com/story/571…

Yesterday from FirstWord Pharma's Twitter

The study found that inactivating a molecule in the brain linked to inflammation prevents cellular damage in human neurons and delays the progression of ALS in mice hvrd.me/KUXe50NhgvB

Yesterday from Harvard Medical School's Twitter

Contact

INRALS Office Management
(Derks & Derks)
Databankweg 12a
3821 AL Amersfoort
The Netherlands

T +31 33 472 80 87
E info@inrals.com
I www.derksenderks.nl

INRALS B.V.
KvK/CoC 60618604

Share us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Back to Top